Journal article
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Abstract
BACKGROUND: Patients with idiopathic pulmonary fibrosis have a poor overall prognosis and there are few evidence-based drug therapies that reduce mortality.
OBJECTIVE: We aimed to perform a systematic review and meta-analysis to assess whether sildenafil reduces mortality, disease progression and adverse side effects.
Authors
Pitre T; Khalid MF; Cui S; Zhang MC; Husnudinov R; Mah J; Helmczi W; Su J; Guy B; Scallan C
Journal
Pulmonary Pharmacology & Therapeutics, Vol. 73, ,
Publisher
Elsevier
Publication Date
June 2022
DOI
10.1016/j.pupt.2022.102128
ISSN
1094-5539